Ashraf S. Yousif

Dr. Ashraf S. Yousif

Ragon Institute of MGH, MIT and Harvard, 400 Technology Square, Cambridge, MA 02139, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Cell
Verified
Journal Article
Open access
CZCarly G.K. Ziegler
Carly G.K. Ziegler
SASamuel J. Allon
Samuel J. Allon
SNSarah K. Nyquist
Sarah K. Nyquist
IMIan M. Mbano
Ian M. Mbano
VMVincent N. Miao
Vincent N. Miao
KZKun Zhang
Kun Zhang
There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry. The cell subsets targeted by SARS-CoV-2 in host tissues and the factors that regulate ACE2 expression remain unknown. Here, we leverage human, non-human primate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover putative targets of SARS-CoV-2 among tissue-resident cell subsets. We identify ACE2 and TMPRSS2 co-expressing cells within lung type II pneumocytes, ileal absorptive enterocytes, and nasal goblet secretory cells. Strikingly, we discovered that ACE2 is a human interferon-stimulated gene (ISG) in vitro using airway epithelial cells and extend our findings to in vivo viral infections. Our data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection.

3 August 2018 in Science Immunology
Verified
Journal Article
Open access
PDF file
GLGiuseppe Lofano
Giuseppe Lofano
MGMatthew J. Gorman
Matthew J. Gorman
AYAshraf S. Yousif
Ashraf S. Yousif
WYWen-Han Yu
Wen-Han Yu
JFJulie Fox
Julie Fox
GAGalit Alter
Galit Alter
HIV-specific antibody sialylation enhances humoral immunity via increased antigen deposition within B cell follicles in a complement-dependent manner.

1 October 2019 in Immunity
Verified
Journal Article
Closed access
MSMaya Sangesland
Maya Sangesland
LRLarance Ronsard
Larance Ronsard
SKSamuel W. Kazer
Samuel W. Kazer
JBJulia Bals
Julia Bals
SBSeyhan Boyoglu-Barnum
Seyhan Boyoglu-Barnum
DLDaniel Lingwood
Daniel Lingwood

1 July 2014 in Molecular Cell
Verified
Journal Article
Closed access
ASAndre Stanlie
Andre Stanlie
AYAshraf S. Yousif
Ashraf S. Yousif
HAHideo Akiyama
Hideo Akiyama
THTasuku Honjo
Tasuku Honjo
NBNasim A. Begum
Nasim A. Begum

3 March 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AYAshraf S. Yousif
Ashraf S. Yousif
ASAndre Stanlie
Andre Stanlie
SMSamiran Mondal
Samiran Mondal
THTasuku Honjo
Tasuku Honjo
NBNasim A. Begum
Nasim A. Begum
Activation-induced cytidine deaminase (AID) is essential to class-switch recombination (CSR) and somatic hypermutation (SHM) in both V region SHM and S region SHM (s-SHM). Uracil DNA glycosylase (UNG), a member of the base excision repair (BER) complex, is required for CSR. Strikingly, however, UNG deficiency causes augmentation of SHM, suggesting involvement of distinct functions of UNG in SHM and CSR. Here, we show that noncanonical scaffold functions of UNG regulate s-SHM negatively and CSR positively. The s-SHM suppressive function of UNG is attributed to the recruitment of faithful BER components at the cleaved DNA locus, with competition against error-prone polymerases. By contrast, the CSR-promoting function of UNG enhances AID-dependent S-S synapse formation by recruiting p53-binding protein 1 and DNA-dependent protein kinase, catalytic subunit. Several loss-of-catalysis mutants of UNG discriminated CSR-promoting activity from s-SHM suppressive activity. Taken together, the noncanonical function of UNG regulates the steps after AID-induced DNA cleavage: error-prone repair suppression in s-SHM and end-joining promotion in CSR.

1 August 2020 in Cell Reports
Verified
Journal Article
Open access
MSMaya Sangesland
Maya Sangesland
AYAshraf S. Yousif
Ashraf S. Yousif
LRLarance Ronsard
Larance Ronsard
SKSamuel W. Kazer
Samuel W. Kazer
AZAlex Lee Zhu
Alex Lee Zhu
DLDaniel Lingwood
Daniel Lingwood
B cell receptors (BCRs) display a combination of variable (V)-gene-encoded complementarity determining regions (CDRs) and adaptive/hypervariable CDR3 loops to engage antigens. It has long been proposed that the former tune for recognition of pathogens or groups of pathogens. To experimentally evaluate this within the human antibody repertoire, we perform immune challenges in transgenic mice that bear diverse human CDR3 and light chains but are constrained to different human VH-genes. We find that, of six commonly deployed VH sequences, only those CDRs encoded by IGHV1-2∗02 enable polyclonal antibody responses against bacterial lipopolysaccharide (LPS) when introduced to the bloodstream. The LPS is from diverse strains of gram-negative bacteria, and the VH-gene-dependent responses are directed against the non-variable and universal saccrolipid substructure of this antigen. This reveals a broad-spectrum anti-LPS response in which germline-encoded CDRs naturally hardwire the human antibody repertoire for recognition of a conserved microbial target.